Tasigna Lawsuit Moves Forward, After Interlocutory Appeal of Preemption Ruling Denied
A federal judge determined the lawsuit was not barred due to preemption laws, after plaintiff brought evidence suggesting Novartis had new information which could have led to updated label warnings.